Volume 12 Issue 1
Jan.  2021
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2021  >  12(1): 70-76
Lyu Guangna, Li Ning, Ning Yuan, et al. Multi-disciplinary team on acute heart failure complicated with respiratory failure after allograft nephrectomy[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 70-76. doi: 10.3969/j.issn.1674-7445.2021.01.011
Citation: Lyu Guangna, Li Ning, Ning Yuan, et al. Multi-disciplinary team on acute heart failure complicated with respiratory failure after allograft nephrectomy[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 70-76. doi: 10.3969/j.issn.1674-7445.2021.01.011
shu

Multi-disciplinary team on acute heart failure complicated with respiratory failure after allograft nephrectomy

doi: 10.3969/j.issn.1674-7445.2021.01.011

  • Department of Renal Transplantation, the Second People's Hospital of Shanxi Province, Taiyuan 030012, China

More Information
  • Corresponding author: Li Ning, E-mail:SXTYLining666@126.com
  • Received Date: 2020-12-01
    Available Online: 2021-01-19
  • Publish Date: 2021-01-19
    Abstract
  •   Objective  To evaluate the effect of multi-disciplinary team (MDT) on acute heart failure (AHF) complicated with respiratory failure after allograft nephrectomy.  Methods  MDT discussion was performed on a patient with hemorrhagic shock caused by sudden renal graft hemorrhage, who developed acute myocardial infarction (AMI) with AHF, acute pulmonary congestion, pulmonary infection and acute respiratory failure 2 weeks after allograft nephrectomy. And treatment plan was formulated and effect evaluation was conducted.  Results  Based on the opinions of MDT discussion, the patient was given nasal high-flow oxygen therapy, continuous veno-venous hemodiafiltration (CVVHDF) to reduce cardiac load, anticoagulant, dilating blood vessels, reducing myocardial oxygen consumption, improving myocardial remodeling, lipid regulation, anti-infection, nutritional support, and other comprehensive treatment. The clinical outcome of the patient was good and regular hemodialysis treatment was resumed.  Conclusions  Application of MDT pattern helps to formulate a comprehensive and effective individualized treatment plan for patients with AHF and respiratory failure after allograft nephrectomy, which can enhance clinical treatment effects and improve prognosis of patient.

     

    • FullText(HTML)
  • loading
    • References(25)
  • [1]
    AL MAMUN M, RUMANA N, KITA Y, et al. Combining the effects of conventional risk factors and environmental triggering factors while studying seasonality in acute myocardial infarction[J]. Environ Pollut, 2014, 189:252-253. DOI: 10.1016/j.envpol.2014.03.012.
    [2]
    关天俊.慢性肾脏病与急性心肌梗死[J].肾脏病与透析肾移植杂志, 2014, 23(4):351-352. https://www.cnki.com.cn/Article/CJFDTOTAL-SZBY201404010.htm

    GUANG TJ. Chronic kidney disease and acute myocardial infarction[J].Chin J Nephrol Dial Transplant, 2014, 23(4):351-352. https://www.cnki.com.cn/Article/CJFDTOTAL-SZBY201404010.htm
    [3]
    ZANCHETTI A, THOMOPOULOS C, PARATI G. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal[J]. Circ Res, 2015, 116(6):1058-1073. DOI: 10.1161/CIRCRESAHA. 116.303641.
    [4]
    FISHMAN JA. Infection in organ transplantation[J]. Am J Transplant, 2017, 17(4):856-879. DOI: 10.1111/ajt.14208.
    [5]
    ZHANG H, WANG K, CHEN H, et al. The double-edged sword of immunosuppressive therapy in kidney transplantation: a rare case report of pulmonary mucormycosis post-transplant and literature review[J]. Front Med (Lausanne), 2020, 7:500. DOI: 10.3389/fmed.2020.00500.
    [6]
    陆再英, 钟南山.内科学[M].第7版.北京:人民卫生出版社, 2011:284.
    [7]
    POMOZOVA TP, LYKOV YV, KOMAROVA IS, et al. Clinical and laboratory features of primary acute myocardial infarction in patients with obstructive and non-obstructive coronary atherosclerosis[J]. Kardiologiia, 2019, 59(10S):41-51. DOI: 10.18087/cardio.2640.
    [8]
    国家心血管病中心.中国心血管病报告2016[M].北京:中国大百科全书出版社, 2017.
    [9]
    中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志, 2018, 46(10):760-789. DOI: 10.3760/cma.j.issn.0253-3758.2018.10.004.

    Heart Failure Group of Branch of Cardiovascular Medicine of Chinese Medical Association, Heart Failure Professional Committee of Chinese Medical Doctor Association, Editorial Committee of Chinese Journal of Cardiology. Chinese guidelines for the diagnosis and treatment of heart failure (2018)[J]. Chin J Cardiol, 2018, 46(10):760-789. DOI: 10.3760/cma.j.issn.0253-3758.2018.10.004.
    [10]
    ZHANG Y, ZHANG J, BUTLER J, et al. Contemporary epidemiology, management, and outcomes of patients hospitalized for heart failure in China: results from the China Heart Failure (China-HF) Registry[J]. J Card Fail, 2017, 23(12):868-875. DOI: 10.1016/j.cardfail.2017.09.014.
    [11]
    KRZYSZTOFIK JM, SOKOLSKI M, KOSOWSKI M, et al. Acute heart failure in patients admitted to the emergency department with acute myocardial infarction[J]. Kardiol Pol, 2017, 75(4):306-315. DOI: 10.5603/KP.a2016.0178.
    [12]
    URIOL RIVERA MG, CABELLO PELEGRIN S, BALLESTER RUIZ C, et al. Impact of a multidisciplinary team for the management of thrombotic microangiopathy[J]. PLoS One, 2018, 13(11):e0206558. DOI: 10.1371/journal.pone.0206558.
    [13]
    LU J, JIANG Y, QIAN M, et al. The improved effects of a multidisciplinary team on the survival of breast cancer patients: experiences from China[J]. Int J Environ Res Public Health, 2019, 17(1):277. DOI: 10.3390/ijerph17010277.
    [14]
    PACKER M, O'CONNOR C, MCMURRAY JJV, et al. Effect of ularitide on cardiovascular mortality in acute heart failure[J]. N Engl J Med, 2017, 376(20):1956-1964. DOI: 10.1056/NEJMoa1601895.
    [15]
    王紫晨, 谭静, 何婧瑜, 等.乌拉地尔和硝酸甘油治疗老年高血压合并心房颤动患者急性左心功能衰竭的效果[J].中国心血管杂志, 2016, 21(3):33-38. DOI:10. 3969/j.issn.1007-5410.2016.03.007.

    WANG ZC, TAN J, HE JY, et al. Therapeutic effects of urapidil and nitroglycerin for treatment of hypertension and atrial fibrillation in elderly patients with acute heart failure[J]. Chin J Cardiovasc Med, 2016, 21(3):33-38. DOI: 10.3969/j.issn.1007-5410.2016.03.007.
    [16]
    张安吉, 王婷, 张阿宁.新活素对老年急性失代偿期心力衰竭患者心功能及尿量的影响[J].中国老年学杂志, 2017, 37(18):4533-4534. DOI:10.3969/j.issn.1005-9202. 2017.18.045.

    ZHANG AJ, WANG T, ZHANG AN. Effect of neovasin on cardiac function and urine output in elderly patients with acute decompensated heart failure[J]. Chin J Gerontol, 2017, 37(18):4533-4534. DOI:10.3969/j.issn. 1005-9202.2017.18.045.
    [17]
    重组人脑利钠肽多中心研究协作组.重组人脑利钠肽治疗心力衰竭安全性和疗效的开放性随机对照多中心临床研究[J].中华心血管病杂志, 2011, 39(4):305-308. DOI: 10.3760/cma.j.issn.0253-3758.2011.04.005.

    Multicenter Clinical Study Group of Recombinant Human Brain Natriuretic Peptide. Efficacy and safety of recombinant human brain natriuretic peptide in heart failure: a multicenter, randomized, open label, controlled study[J]. Chin J Cardiol, 2011, 39(4):305-308. DOI: 10.3760/cma.j.issn.0253-3758.2011.04.005.
    [18]
    WANG S, QU X, QU Y, et al. The effect of B-type brain natriuretic peptide on patients with acute decompensated heart failure coexisting with lung cancer: a randomized controlled clinical trial[J]. Pharmazie, 2014, 69(3):212-216.
    [19]
    KHDER Y, SHI V, MCMURRAY JJV, et al. Sacubitril/valsartan (LCZ696) in heart failure[J]. Handb Exp Pharmacol, 2017, 243:133-165. DOI: 10.1007/164_2016_77.
    [20]
    PFAU D, THORN SL, ZHANG J, et al. Angiotensin receptor neprilysin inhibitor attenuates myocardial remodeling and improves infarct perfusion in experimental heart failure[J]. Sci Rep, 2019, 9(1):5791. DOI: 10.1038/s41598-019-42113-0.
    [21]
    张凯, 李广平.伊伐布雷定在心血管疾病中的应用进展[J].中国心血管杂志, 2017, 22(2):159-160, 封3. DOI: 10.3969/j.issn.1007-5410.2017.02.019.

    ZHANG K, LI GP. Progress in application of ivabradine in cardiovascular diseases[J]. Chin J Cardiovasc Med, 2017, 22(2):159-160, cover3. DOI:10.3969/j.issn.1007-5410. 2017.02.019.
    [22]
    高晓飞, 许轶洲.伊伐布雷定在心血管疾病中的现状与进展[J].心血管病学进展, 2015, 36(3):346-348. DOI: 10.3969/j.issn.1004-3934.2015.03.029.

    GAO XF, XU YZ. The status and progress in using ivabradine in cardiovascular disease[J]. Adv Cardiovasc Dis, 2015, 36(3):346-348. DOI:10.3969/j.issn.1004-3934. 2015.03.029.
    [23]
    时珊珊, 吴晓羽.伊伐布雷定在心血管疾病中的临床研究进展[J].中国循环杂志, 2015, 30(6):613-616. DOI: 10.3969/j.issn.1000-3614.2015.06.028.

    SHI SS, WU XY. Advances in the clinical study of ivabradine in cardiovascular disease[J]. Chin Circ J, 2015, 30(6):613-616. DOI: 10.3969/j.issn.1000-3614.2015.06.028.
    [24]
    ZEYMER U, HOCHADEL M, KARCHER AK, et al. Procedural success rates and mortality in elderly patients with percutaneous coronary intervention for cardiogenic shock[J]. JACC Cardiovasc Interv, 2019, 12(18):1853-1859. DOI: 10.1016/j.jcin.2019.04.027.
    [25]
    JI Z, ZHANG R, LU W, et al. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and Meta-analysis[J]. Ir J Med Sci, 2020, 189(1):119-131. DOI: 10.1007/s11845-019-02034-3.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (243) PDF downloads(21) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return